Trials
Search / Trial NCT05640427

Effect of Different Doses of Dexmedetomidine on Cerebral Oxygen Saturation and Postoperative Anxiety in Elderly Patients

Launched by THE FIRST HOSPITAL OF QINHUANGDAO · Dec 6, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

Dexmedetomidine Anxiety

ClinConnect Summary

A total of 105 patients who were admitted to The First Hospital of Qinhuangdao for laparoscopic surgery and divided into control group (group C), dexmedetomidine doses of 0.2 μg/kg (group D1), dexmedetomidine doses of 0.5 μg/kg (group D2).

105 patients were randomized equally into 3 groups. 35 cases in each group. Group C received general anesthesia without dexmedetomidine, groups D1 received general anesthesia with intravenous pump of 0. 2μg/kg/h dexmedetomidine, groups D2 received general anesthesia with intravenous pump of 0. 5μg/kg/h dexmedetomidine.SBP(Systolic Blood Pressure),DP(Dias...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 65 years or older who underwent elective laparoscopic surgery under general anesthesia
  • BMI less than 30 kg/m2
  • American Society of Anesthesiologists (ASA) grades I-III
  • The score of Mini Mental state examination≥24
  • Exclusion Criteria:
  • Patients with heart, lung and other vital organ disorders
  • The score of Mini Mental state examination≤23
  • Preoperative psychiatric disorders or long-term use of drugs affecting the psychiatric system
  • Have severe visual, hearing, speech impairment or other inability to communicate with the visitor
  • Refuse to sign informed consent
  • known preoperative left ventricular ejection fraction less than 30%, sick sinus syndrome, severe sinus bradycardia (\<50 beats per min \[bpm\]), or second-degree or greater atrioventricular block without pacemaker

Trial Officials

Shujuan Liang, Master

Study Director

The First hosptial of Qinhuangdao

Hua Zhou, Master

Study Chair

The First hosptial of Qinhuangdao

About The First Hospital Of Qinhuangdao

The First Hospital of Qinhuangdao is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Renowned for its comprehensive range of services and state-of-the-art facilities, the hospital actively engages in clinical trials to explore new therapeutic interventions and improve patient outcomes. With a multidisciplinary team of experienced healthcare professionals, the First Hospital of Qinhuangdao is committed to upholding the highest standards of ethical research practices while fostering collaboration with local and international partners in the medical community.

Locations

Qinhuangdao, Hebei, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials